Skip to main content
. Author manuscript; available in PMC: 2014 Jul 12.
Published in final edited form as: Adv Mater. 2013 Apr 15;25(26):10.1002/adma.201300343. doi: 10.1002/adma.201300343

Figure 4.

Figure 4

CD-1 mice were treated with 150μg epirubicin (n=5), 833μg of ND (n=5), equivalent of untargeted NDLP (n=3), targeted NDLP (n=4) or vehicle control (n=5) for 24 hours prior to hematological and serum chemistry analysis. No significant differences between treatment and vehicle control groups were observed. Gray region indicates expected normal range for 6-8 week-old, female, CD-1 mice. WBC – white blood cells, PLT-platelets, BA-basophils, EO-eosinophils, MO – monocytes, LY – lymphocytes, NE – neutrophils, RBC – red blood cells, Hgb – hemoglobin, Hct – hematocrit, ALK – alkaline phosphatase, AST – aspartate aminotransferase, ALT – alanine aminotransferase, TPR – total protein, TBIL – total bilirubin, BUN – blood urea nitrogen.